Bank of America’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,943
| Closed | -$67.6K | – | 8413 |
|
|
2023
Q4 | $67.6K | Buy |
5,943
+5,868
| +7,824% | +$46.1K | ﹤0.01% | 6512 |
|
|
2023
Q3 | $302 | Hold |
75
| – | – | ﹤0.01% | 7364 |
|
|
2023
Q2 | $533 | Sell |
75
-2,170
| -97% | -$15K | ﹤0.01% | 7311 |
|
|
2023
Q1 | $16.7K | Buy |
2,245
+2,009
| +851% | +$16.9K | ﹤0.01% | 6804 |
|
|
2022
Q4 | $1.71K | Buy |
236
+29
| +14% | +$244 | ﹤0.01% | 7266 |
|
|
2022
Q3 | $2K | Buy |
207
+92
| +80% | +$1.72K | ﹤0.01% | 7612 |
|
|
2022
Q2 | $2K | Sell |
115
-370
| -76% | -$9.58K | ﹤0.01% | 7819 |
|
|
2022
Q1 | $24K | Sell |
485
-465
| -49% | -$24.1K | ﹤0.01% | 7462 |
|
|
2021
Q4 | $72K | Sell |
950
-244
| -20% | -$16.7K | ﹤0.01% | 7041 |
|
|
2021
Q3 | $94K | Buy |
1,194
+597
| +100% | +$60K | ﹤0.01% | 6759 |
|
|
2021
Q2 | $83K | Sell |
597
-412
| -41% | -$78.6K | ﹤0.01% | 6611 |
|
|
2021
Q1 | $210K | Buy |
1,009
+557
| +123% | +$112K | ﹤0.01% | 5998 |
|
|
2020
Q4 | $75K | Sell |
452
-14
| -3% | -$2.16K | ﹤0.01% | 6133 |
|
|
2020
Q3 | $79K | Sell |
466
-160
| -26% | -$23.1K | ﹤0.01% | 5802 |
|
|
2020
Q2 | $103K | Sell |
626
-137
| -18% | -$21.4K | ﹤0.01% | 5659 |
|
|
2020
Q1 | $88K | Sell |
763
-29
| -4% | -$4.08K | ﹤0.01% | 5595 |
|
|
2019
Q4 | $117K | Buy |
792
+359
| +83% | +$54.5K | ﹤0.01% | 5934 |
|
|
2019
Q3 | $58K | Buy |
433
+246
| +132% | +$34.6K | ﹤0.01% | 6260 |
|
|
2019
Q2 | $24K | Buy |
187
+137
| +274% | +$15.9K | ﹤0.01% | 6528 |
|
|
2019
Q1 | $5K | Buy |
+50
| New | +$6.57K | ﹤0.01% | 6806 |
|
Bank of America's HARP Position: Q1 2024 in Review
Bank of America sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 5,943 shares — an estimated $67.6K sold.
Bank of America first reported a position in HARP in Q1 2019 and held it in 20 quarters. The position peaked at $210K in Q1 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- Bank of America reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Bank of America sold 5,943 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $67.6K.
- Bank of America first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- Bank of America's Harpoon Therapeutics, Inc. Common Stock position peaked at $210K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.